Bal Pharma Limited (NSE: BALPHARMA)
India
· Delayed Price · Currency is INR 121.00
-1.95 (-1.59%)
Dec 26, 2024, 3:14 PM IST
Bal Pharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 3,243 | 3,392 | 3,042 | 2,812 | 2,505 | 1,711 | Upgrade
|
| Revenue | 3,243 | 3,392 | 3,042 | 2,812 | 2,505 | 1,711 | Upgrade
|
| Revenue Growth (YoY) | 0.73% | 11.51% | 8.18% | 12.25% | 46.43% | -23.96% | Upgrade
|
| Cost of Revenue | 1,823 | 1,974 | 1,782 | 1,722 | 1,541 | 876.47 | Upgrade
|
| Gross Profit | 1,420 | 1,418 | 1,260 | 1,091 | 963.84 | 834.47 | Upgrade
|
| Selling, General & Admin | 628.77 | 614.26 | 560.62 | 478.19 | 425.59 | 508.43 | Upgrade
|
| Other Operating Expenses | 466.5 | 479.25 | 434.22 | 372.61 | 273.81 | 277.19 | Upgrade
|
| Operating Expenses | 1,196 | 1,194 | 1,086 | 941.21 | 794.62 | 861.84 | Upgrade
|
| Operating Income | 224.79 | 224.11 | 174.24 | 149.31 | 169.22 | -27.37 | Upgrade
|
| Interest Expense | -133.39 | -129.05 | -104.96 | -88.75 | -105.39 | -107.74 | Upgrade
|
| Interest & Investment Income | 5.6 | 5.6 | 2.31 | 3.7 | 3.14 | 3.88 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.11 | -9.11 | -14.23 | 6.85 | -18.6 | 4.62 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.24 | -1.91 | -11.2 | -1.71 | -6.81 | -10.73 | Upgrade
|
| EBT Excluding Unusual Items | 89.13 | 89.65 | 46.16 | 69.39 | 41.56 | -137.34 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.15 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.83 | 0.83 | 0.39 | 12.34 | 0.21 | 0.53 | Upgrade
|
| Asset Writedown | - | - | - | - | -1.06 | - | Upgrade
|
| Pretax Income | 89.95 | 90.47 | 47.48 | 91.82 | 41.02 | -136.89 | Upgrade
|
| Income Tax Expense | 13.13 | 16.02 | 21.29 | 34.77 | -6.1 | -7.97 | Upgrade
|
| Earnings From Continuing Operations | 76.82 | 74.46 | 26.19 | 57.05 | 47.12 | -128.92 | Upgrade
|
| Minority Interest in Earnings | -0.19 | -0.54 | -0.48 | -0.93 | 0.3 | 6.74 | Upgrade
|
| Net Income | 76.63 | 73.92 | 25.72 | 56.12 | 47.42 | -122.18 | Upgrade
|
| Net Income to Common | 76.63 | 73.92 | 25.72 | 56.12 | 47.42 | -122.18 | Upgrade
|
| Net Income Growth | 139.08% | 187.44% | -54.17% | 18.33% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 16 | 16 | 16 | 15 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 16 | 15 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | -0.47% | 0.73% | 5.86% | 4.39% | 0.19% | - | Upgrade
|
| EPS (Basic) | 4.74 | 4.68 | 1.64 | 3.79 | 3.34 | -8.62 | Upgrade
|
| EPS (Diluted) | 4.74 | 4.68 | 1.64 | 3.79 | 3.34 | -8.62 | Upgrade
|
| EPS Growth | 140.22% | 185.35% | -56.71% | 13.36% | - | - | Upgrade
|
| Free Cash Flow | 132.72 | 118.26 | -161.83 | 183.26 | 189.71 | 181.8 | Upgrade
|
| Free Cash Flow Per Share | 8.21 | 7.48 | -10.31 | 12.36 | 13.36 | 12.83 | Upgrade
|
| Dividend Per Share | 1.200 | 1.200 | 1.000 | 1.000 | 1.000 | - | Upgrade
|
| Dividend Growth | - | 20.00% | 0% | 0% | - | - | Upgrade
|
| Gross Margin | 43.79% | 41.81% | 41.43% | 38.78% | 38.47% | 48.77% | Upgrade
|
| Operating Margin | 6.93% | 6.61% | 5.73% | 5.31% | 6.75% | -1.60% | Upgrade
|
| Profit Margin | 2.36% | 2.18% | 0.85% | 2.00% | 1.89% | -7.14% | Upgrade
|
| Free Cash Flow Margin | 4.09% | 3.49% | -5.32% | 6.52% | 7.57% | 10.63% | Upgrade
|
| EBITDA | 294.98 | 290.7 | 237.77 | 219.81 | 244.26 | 28.1 | Upgrade
|
| EBITDA Margin | 9.09% | 8.57% | 7.82% | 7.82% | 9.75% | 1.64% | Upgrade
|
| D&A For EBITDA | 70.19 | 66.59 | 63.54 | 70.51 | 75.03 | 55.47 | Upgrade
|
| EBIT | 224.79 | 224.11 | 174.24 | 149.31 | 169.22 | -27.37 | Upgrade
|
| EBIT Margin | 6.93% | 6.61% | 5.73% | 5.31% | 6.75% | -1.60% | Upgrade
|
| Effective Tax Rate | 14.60% | 17.70% | 44.84% | 37.87% | - | - | Upgrade
|
| Revenue as Reported | 3,277 | 3,421 | 3,052 | 2,864 | 2,517 | 1,729 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.